
89Zr-PET imaging to predict tumor uptake of 177Lu-NNV003,

89Zr-panitumumab PET imaging for preoperative assessment of,

A destabilizing Y891D mutation in activated EGFR impairs,

The Scientific and Clinical Potentials of Imaging Cytotoxic,

Evaluation of Candidate Theranostics for 227Th/89Zr Paired,

89 Zr-nimotuzumab for immunoPET imaging of epidermal growth,

Full article: Serum total acid phosphatase for monitoring,

Tim Bracey on X: ,

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement,

Potential role of the HOXD8 transcription factor in